<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20221212056801N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-01-09</date_registration>
      <primary_sponsor>Sabzevar University of Medical Sciences</primary_sponsor>
      <public_title>Investigating the effect of aromatherapy with passiflora oil on sleep quality and life balance of patients undergoing hemodialysis</public_title>
      <acronym></acronym>
      <scientific_title>Investigating the effect of aromatherapy with passiflora oil on sleep quality and life balance of patients undergoing hemodialysis</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-01-27</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>72</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/67698</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Triple blinded, Placebo: Used, Assignment: Parallel, Purpose: Supportive, Randomization description: In each treatment center, patients will be allocated to intervention and control groups by permuted block randomization. For this, we are about to have 12 blocks of 6 members. According to the number of patients in each of the centers (70 patients in Kashmar, 28 patients in Bardaskan and 21 patients in Khalilabad), 3 blocks will be allocated in Bardaskan center, 3 blocks in Khalilabad center, and 6 blocks in Kashmar center. Random Allocation software will be used for determination of random blocks. In order to hide the random allocation, we will use opaque sealed envelopes with a random sequence. In this method, which is abbreviated as the SNOSE method, after creating a random sequence with the help of software, a number of envelopes will be prepared based on the sample size, each of the created random sequences will be recorded on cards and placed inside the envelopes. Then the envelopes are numbered in the same order as the created sequence. Then, based on the order in which the eligible participants entered the study, one of the envelopes will be opened and the group assigned to the patient will be determined, Blinding description: For blinding purposes, random allocation will be done by one of the investigators, then the study will be performed by another investigator. In this way, the researcher who provides the oils to the patients is not aware of the type of oil and patients will not be informed about the type of oil either. Patients will receive identical packages. Finally, the data will be prepared for analysis. At the time of analysis, the researcher will not be aware of the patient grouping. In this case, the study is three-way blind.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Chronic renal failure.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: For six weeks, the intervention group is requested to put two pieces of cotton soaked in 7 drops of 30% concentrated  passiflora oil each night on both sides of their pillow before sleeping, inside a cellophane container designed by the researcher. They have to put it away and throw out next morning. Intervention 2: Control group: For six weeks, the Control group is requested to put two pieces of cotton soaked in 7 drops of  sweet almond oil each night on both sides of their pillow before sleeping, inside a cellophane container designed by the researcher. They have to put it away and throw out next morning.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Part of the research sample data after deid entification will be shared

When:
After collecting and analyzing the data, the results will be published in the form of an article became

To whom:
The results will be published for all researchers working in the class

Conditions:
The results of this study can be used by all people who are in the field of treatment Caring for patients with chronic kidney failure and undergoing hemodialysis are being used.

Where to obtain:
Applicants can contact Ms. Marzieh Dolatshahi at the address of Sabzevar University of Medical Sciences, Faculty of Nursing and Midwifery, refer to the student research committee unit

How to obtain:
Applicants can obtain documents after submitting an application to the student research committee and obtaining the necessary permits.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Marzieh Dolatshahi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 49,th6 Shahid Sadeghi Street</address>
        <city>Kashmar</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9671773453</zip>
        <telephone>+98 51 5772 3106</telephone>
        <email>dolatshahi1784@gmail.com</email>
        <affiliation>Sabzevar University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mojgan Ansari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Boulevard nuclear shohaday. Sabzevar University of Medical Sciences campus</address>
        <city>Sabzevar</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9617913112</zip>
        <telephone>+98 51 4401 8300</telephone>
        <email>mojganansari01@gmail.com</email>
        <affiliation>Sabzevar University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>complete awareness
Age between 19-70 years
A history of at least 6 months of hemodialysis
dialysis twice a week for three hours each time
Having a Sleep Quality score of 5 and above 5 of the above 5 based on the Pittsburgh questionnaire</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>70 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Presence of smell disorder
Severe mental disorder and the use of drugs or sedatives
respiratory disorder such as asthma
History of allergy to herbal medicine
skin sensitivity following the test of passiflora oil on the front part of the patient's forearm</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>N18.4</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Chronic kidney disease, stage 4 (severe)</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: For six weeks, the intervention group is requested to put two pieces of cotton soaked in 7 drops of 30% concentrated  passiflora oil each night on both sides of their pillow before sleeping, inside a cellophane container designed by the researcher. They have to put it away and throw out next morning</i_keyword>
      <i_keyword>Control group: For six weeks, the Control group is requested to put two pieces of cotton soaked in 7 drops of  sweet almond oil each night on both sides of their pillow before sleeping, inside a cellophane container designed by the researcher. They have to put it away and throw out next morning</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Sleep quality score in the Pittsburgh Questionnaire. Timepoint: Before the start of the study and 6 weeks after the start of aromatherapy with passiflora oil. Method of measurement: Pittsburgh Sleep Quality Questionnaire.</prim_outcome>
      <prim_outcome>Life balance score in Matuska questionnaire. Timepoint: Before the start of the study and 6 weeks after the start of aromatherapy with passiflora oi. Method of measurement: Matuska's Life Balance Questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Sleep quality score in the Pittsburgh Questionnaire. Timepoint: Before the start of the study and 6 weeks after the start of aromatherapy with passiflora oil. Method of measurement: Pittsburgh Sleep Quality Questionnaire.</sec_outcome>
      <sec_outcome>Life balance score in Matuska questionnaire. Timepoint: Before the start of the study and 6 weeks after the start of aromatherapy with passiflora oil. Method of measurement: Matuska's Life Balance Questionnaire.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Sabzevar University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-01-01</approval_date>
        <contact_name>research Ethics committee of Sabzevar University of Medical Sciences</contact_name>
        <contact_address>Blvd. Shohada Nuclear, Sabzevar University of Medical Sciences campus Sabzevar Razavi Khorasan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
